Endometrial Cancer News and Research

RSS

No evidence that taking estrogen alone increases the risk of breast cancer in postmenopausal women

The findings come three years after a related WHI study found that a different type of hormone therapy - which combined estrogen and progestin - did result in a higher risk of breast cancer among postmenopausal women.

13 Apr 2006

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

The results contrast with the previously reported WHI Estrogen plus Progestin Trial, which found an increase in breast cancer over about 5 years among those taking combined hormone therapy.

11 Apr 2006

Treatment of uterine (endometrial) cancer by laparoscopy gives better patient quality of life

Laparoscopy proves safe, reduces hospital stay, and results in improved quality of life.

27 Mar 2006

Tamoxifen reduces the risk of invasive and noninvasive breast cancer

Data from additional years of follow-up of a large randomized placebo-controlled clinical trial of tamoxifen for the prevention of breast cancer confirm that the drug reduces the risk of invasive and noninvasive breast cancer, according to a report that appears in the current issue of the Journal of the National Cancer Institute.

21 Nov 2005

Ospemifine may also help to prevent breast cancer

A tamoxifen-like drug developed by UC Davis and Finnish researchers, now in clinical testing as a treatment for vaginal atrophy, may also help to prevent breast cancer, two preliminary studies suggest.

3 Nov 2005

Diet high in soy does not increase the risk of uterine cancer in postmenopausal women

Cline said there has been much debate about whether high levels of dietary soy are safe for postmenopausal women. Soy products are sometimes sold as a natural alternative to traditional estrogen therapy, which does increase the risk of endometrial cancer.

3 Nov 2005

Testing for specific breast cancer genes unadvisable if no family history of disease exists

According to the Preventive Services Task Force in the U.S., routine testing for mutations in the BRCA1 and BRCA2 genes, which have been linked to breast and ovarian cancer, are not advised unless women have a family history of the disease.

7 Sep 2005

Complex chemotherapy cocktails offers pluses, minuses in advanced endometrial cancer

Complex chemotherapy cocktails offer about one extra month of life to patients with end-stage endometrial cancer but also can result in severe, possibly fatal, side effects, according to the first systematic review of studies addressing the topic.

1 Sep 2005

Birth control pill increases risks of cervical and breast cancer

Scientists are now saying that women who take the birth control pill could be increasing their risk of cervical and breast cancer.

31 Jul 2005

Approval sought for Femara in early post-surgery use

Approval is being sought in the U.S. and Europe, by Swiss drug makerNovartis, for its breast-cancer drug Femara to be used immediately after surgery to help older women fight tumours.

12 Jul 2005

Exercise and weight control reduces odds of developing breast cancer

Women who exercise more and keep their weight under control may dramatically reduce their odds of developing breast cancer, a population-based study by a team of investigators at Meharry Medical College and the Vanderbilt-Ingram Cancer Center suggests.

9 Jun 2005

HRT now linked to cancer of the womb

A new study of more than 700,000 women has found, say the researchers, that Hormone replacement therapy (HRT) can increase the risk of cancer of the womb, depending on the form of HRT used.

1 May 2005

Risk of womb cancer now linked to some hormone-replacement therapy

Researchers in the UK say that certain types of hormone-replacement therapy (HRT) increase a woman’s risk of womb cancer while others do not. The study found that though many post-menopausal women, who have not had a hysterectomy, use combined HRT because oestrogen only are thought to increase the risk of womb cancer, little information exists on the incidence of womb cancer in users of these other therapies.

1 May 2005

Tamoxifen still not popular with women at risk of breast cancer

Tamoxifen still not popular with women at risk of breast cancer A new study has revealed that less than one in five women eligible to take tamoxifen decided to take the drug after being told of its risks and benefits.

11 Apr 2005

African-American women with advanced endometrial cancer have more aggressive tumors than Caucasian women

In two studies of African-American women with endometrial cancer, a group of investigators from Walter Reed Army Medical Center and the National Cancer Institute has found that African-American women with advanced endometrial cancer have more aggressive tumors than Caucasian women, potentially leading to worse outcomes.

21 Mar 2005

Babies who weighed more at birth had higher rates of digestive and lymphatic cancers in adulthood

Medical experts have proposed associations between birth size and rates of adult cancer. To examine this hypothesis, researcher Valerie A. McCormack and colleagues at the London School of Hygiene & Tropical Medicine and the Universities of Uppsala and Stockholm investigated overall and site-specific cancer incidence in relation to birth characteristics in a Swedish population-based cohort.

7 Feb 2005

Broadening treatment to battle recurrence of endometrial cancer

Mayo Clinic researchers studying endometrial cancer have found that patients at risk for relapse based on identified risk factors had a 46 percent probability of experiencing recurrence within five years despite treatment with state-of-the-art therapy.

18 Jan 2005

Does cancer run in families?

If you have a relative with cancer, probably one of the most pressing questions is what your chances are of getting it yourself. In a paper published in PloS Medicine, the premier medical journal freely available online, Laufey Amundadottir and colleagues from deCODE genetics (a company that is using genetics to develop new drug treatments) and Iceland’s National-University Hospital go some way toward answering that question.

28 Dec 2004

Many women at high risk for breast cancer are foregoing tamoxifen

Many women at high risk for breast cancer are foregoing tamoxifen, the first FDA-approved drug for prevention of breast cancer, due to concerns about side effects, increased risk of other cancers, and lack of information, a new study by researchers in Boston shows. The study was published in the December 14 in the Journal of Clinical Oncology.

20 Dec 2004

Study will help cancer survivors treated with radical hysterectomy regain their sexual health

When Linda Mercer underwent a radical hysterectomy to treat her cancer, she found herself and her husband struggling to regain a satisfying sex life.

4 Dec 2004